Robotic and laparoscopic procedures in the urological field

Comparison between robotic and laparoscopic approach to treat urological diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN14196575

Enrollment

500

Registered

2026-07-06

Start date

2026-07-01

Completion date

Unknown

Last updated

2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign and neoplastic urological condition Cancer

Interventions

This observational study enrols patients before undergoing a surgical procedure and follows them prospectively for 5 years after surgery. As the final disease classification and risk stratification de

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who underwent robotic and laparoscopic procedures for urological conditions

Exclusion criteria

Exclusion criteria: 1. Locally advanced or metastatic disease 2. Benign lesion at histopathology 3. Multiple renal masses 4. Coagulopathy or anticoagulants that could not be stopped 5. End-stage renal disease 6. Pregnancy

Design outcomes

Primary

Measure	Time frame
Disease-free survival (DFS) measured using data collected from patient medical records at baseline and 5 years follow up;Duration of the procedure measured using data collected from patient medical records at baseline and 5 years follow up;Neoplastic-related relapse measured using data collected from patient medical records at baseline and 5 years follow up;Bleeding during the procedure measured using data collected from patient medical records at baseline and 5 years follow up;Cost of the procedure measured using data collected from patient medical records at baseline and 5 years follow up	—

Measure

Time frame

Disease-free survival (DFS) measured using data collected from patient medical records at baseline and 5 years follow up;Duration of the procedure measured using data collected from patient medical records at baseline and 5 years follow up;Neoplastic-related relapse measured using data collected from patient medical records at baseline and 5 years follow up;Bleeding during the procedure measured using data collected from patient medical records at baseline and 5 years follow up;Cost of the procedure measured using data collected from patient medical records at baseline and 5 years follow up

—

Countries

France, Greece, Italy, Romania, Russian Federation, Spain

Contacts

Public ContactGiorgio Bozzini

segreteria@fondazioneroute.it+393477945956

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026